Biomedical Mass Spectrometry in Today's and Tomorrow's Clinical Microbiology Laboratories
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Clinical microbiology is a conservative laboratory exercise where base technologies introduced in the 19th century remained essentially unaltered. High-tech mass spectrometry (MS) has changed that. Within a few years following its adaptation to microbiological diagnostics, MS has been introduced, embraced, and broadly accepted by clinical microbiology laboratories throughout the world as an innovative tool for definitive bacterial species identification. Herein, we review the current state of the art with respect to this exciting new technology and discuss potential future applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, the clinically deployed use of wholeprotein MALDI-TOF MS for rapid identification of the species and strain of pathogenic bacteria has been adopted by thousands of hospitals and clinics worldwide 70,71 .”
From How many human proteoforms are there? (2018) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology
Croxatto, A., Prod'hom, G., & Greub, G. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00298.x · Cited by 997
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 561 · cited 1×
“The use of high-performance liquid chromatography (HPLC) in tandem with MS facilitates the detection of a variety of antibody species and even antibody-antigen complexes (17).”
Cherkaoui, A., Hibbs, J., Emonet, S., Tangomo, M., Girard, M., Francois, P., & Schrenzel, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01881-09 · Cited by 527 · cited 1×
“Currently, the major commercial MALDI-TOF MS systems with validated microbial identification capacity are the Bruker Biotyper and the bioMérieux Vitek MS system (the latter developed by AnagnosTec [Germany] and Shimadzu Corporation [Japan]) (5, 25).”
MethodStevenson, L. G., Drake, S. K., & Murray, P. R. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01541-09 · Cited by 424
La Scola, B., & Raoult, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008041 · Cited by 383 · cited 1×
“consensus still has not been reached (11, 22).”
BackgroundFerreira, L., Sánchez-Juanes, F., González-Ávila, M., Cembrero-Fuciños, D., Herrero-Hernández, A., González-Buitrago, J. M., & Muñoz-Bellido, J. L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02215-09 · Cited by 341 · cited 1×
“consensus still has not been reached (11, 22).”
BackgroundBurckhardt, I., & Zimmermann, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00287-11 · Cited by 335 · cited 1×
“Recently, several studies have described MS-mediated detection of degradation of beta-lactam antimicrobials (3, 16, 18).”
BackgroundHrabák, J., Walková, R., Študentová, V., Chudáčková, E., & Bergerová, T. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00984-11 · Cited by 310 · cited 2×
“It was demonstrated that this method has a sensitivity of 97% and a specificity of 98% (18).”
BackgroundDhiman, N., Hall, L., Wohlfiel, S. L., Buckwalter, S. P., & Wengenack, N. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02381-10 · Cited by 294 · cited 1×
“, PCR, sequencing, probe-mediated identification and detection tools, and even some selective culture-based diagnostics, MS technology offers several distinct advantages (7).”
BackgroundWolters, M., Rohde, H., Maier, T., Belmar-Campos, C., Franke, G., Scherpe, S., Aepfelbacher, M., & Christner, M. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.002 · Cited by 247
Martiny, D., Busson, L., Wybo, I., El Haj, R. A., Dediste, A., & Vandenberg, O. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05971-11 · Cited by 238 · cited 1×
“Some microbial species remain more difficult to identify than others using MALDI-TOF; however, this is true for most diagnostic technologies (24).”
BackgroundEl Khéchine, A., Couderc, C., Flaudrops, C., Raoult, D., & Drancourt, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024720 · Cited by 206 · cited 1×
“mycobacteria (10) and their subspecies (30).”
Fortin, T., Salvador, A., Charrier, J. P., Lenz, C., Lacoux, X., Morla, A., Choquet-Kastylevsky, G., & Lemoine, J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800238-mcp200 · Cited by 177 · cited 1×
“More recently, LC-ESI-QqQ has been suggested as a replacement for classical enzymelinked immunosorbent assays (ELISAs) for the quantitation of proteins in complex matrices (12).”
MethodProteomics for routine identification of microorganisms
Welker, M. (2011) · PROTEOMICS · doi:10.1002/pmic.201100049 · Cited by 175 · cited 1×
“Various methods for adequate data interpretation have been described (23, 31).”
MethodSelf-citationBenagli, C., Rossi, V., Dolina, M., Tonolla, M., & Petrini, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016424 · Cited by 168
Dieckmann, R., & Malorny, B. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02418-10 · Cited by 167 · cited 1×
“Specific Salmonella serovars can be equally well grouped on the basis of MS (8).”
BackgroundBille, E., Dauphin, B., Leto, J., Bougnoux, M., Béretti, J., Lotz, A., Suarez, S., Meyer, J., Join‐Lambert, O., Descamps, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03688.x · Cited by 158 · cited 1×
“Andromas (Paris, France) provides an additional database that can be used in combination with the Bruker platform (2).”
BackgroundNagy, E., Becker, S., Sóki, J., Urbán, E. Z., & Kostrzewa, M. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.031336-0 · Cited by 128 · cited 3×
“Currently, the major commercial MALDI-TOF MS systems with validated microbial identification capacity are the Bruker Biotyper and the bioMérieux Vitek MS system (the latter developed by AnagnosTec [Germany] and Shimadzu Corporation [Japan]) (5, 25).”
BackgroundMethodJustesen, U. S., Holm, A., Knudsen, E., Andersen, L. B., Jensen, T. G., Kemp, M., Skov, M. N., Gahrn-Hansen, B., & Møller, J. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05788-11 · Cited by 115
MALDI tissue imaging: from biomarker discovery to clinical applications
Cazares, L. H., Troyer, D. A., Wang, B., Drake, R. R., & Semmes, O. J. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5003-6 · Cited by 101 · cited 1×
“As was initially piloted with various insect species, MALDI-TOF MS can also be used for human tissue imaging (4) and the detection of pathogenic viruses (26).”
BackgroundWybo, I., De Bel, A., Soetens, O., Echahidi, F., Vandoorslaer, K., Van Cauwenbergh, M., & Piérard, D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02321-10 · Cited by 96 · cited 1×
“Apparently, the cifA gene has been acquired by one lineage and has not been further spread by horizontal gene transfer (25, 33).”
BackgroundGlowalla, E., Tosetti, B., Krönke, M., & Krut, O. (2009) · Infection and Immunity · doi:10.1128/iai.00617-08 · Cited by 94 · cited 1×
“specific target proteins can be determined (15).”
Fox, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00971-06 · Cited by 89 · cited 1×
“” Fox hoped that his review would support the acceptance of biophysical diagnostics in general (13).”
BackgroundCharacterization of β-Lactamase Enzyme Activity in Bacterial Lysates using MALDI-Mass Spectrometry
Hooff, G. P., van Kampen, J. J. A., Meesters, R. J. W., van Belkum, A., Goessens, W. H. F., & Luider, T. M. (2011) · Journal of Proteome Research · doi:10.1021/pr200858r · Cited by 81 · cited 3×
“This may facilitate further characterization of the resistance mechanisms involved (16).”
BackgroundKaneshiro, K., Fukuyama, Y., Iwamoto, S., Sekiya, S., & Tanaka, K. (2011) · Analytical Chemistry · doi:10.1021/ac103203v · Cited by 79 · cited 1×
“Chemical modification with aminoquinolines promoted the “ionizability” of saccharides (21).”
BackgroundGaillot, O., Blondiaux, N., Loïez, C., Wallet, F., Lemaître, N., Herwegh, S., & Courcol, R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05429-11 · Cited by 74
B, V. H., Bruynseels, P., Bensaid, M., Boekhout, T., Baere, T. D., Surmont, I., & Mertens, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1383-y · Cited by 73 · cited 1×
“Now, only 6 years later, matrix-assisted laser desorption/ ionization–time of flight mass spectrometry (MALDI-TOF MS) has been embraced by the clinical microbiology community as the nextgeneration tool for definitive species identification of a variety of microorganisms (6, 23, 28).”
BackgroundJuiz, P., Almela, M., Melción, C., Campo, I., Esteban, C., Pitart, C., Marco, F., & Vilà, J. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1449-x · Cited by 62
Intact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections
Scola, B. L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.12 · Cited by 61 · cited 2×
“Now, only 6 years later, matrix-assisted laser desorption/ ionization–time of flight mass spectrometry (MALDI-TOF MS) has been embraced by the clinical microbiology community as the nextgeneration tool for definitive species identification of a variety of microorganisms (6, 23, 28).”
BackgroundMethodSjöholm, M., Dillner, J., & Carlson, J. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01565-07 · Cited by 61 · cited 1×
“As was initially piloted with various insect species, MALDI-TOF MS can also be used for human tissue imaging (4) and the detection of pathogenic viruses (26).”
BackgroundSyrmis, M. W., Moser, R. J., Whiley, D. M., Vaska, V. L., Coombs, G. W., Nissen, M. D., Sloots, T. P., & Nimmo, G. R. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03521.x · Cited by 55 · cited 1×
“Another MALDI-TOF MS system, focused on the analysis of nucleic acids, including PCR products and their derivatives, is offered by Sequenom (San Diego, CA) and uses the proprietary MassArray technology (27).”
MethodThe Future of Biological Mass Spectrometry
Vestal, M. L. (2011) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-011-0108-x · Cited by 33 · cited 1×
“It is noteworthy that the most popular routine diagnostic procedure to date, MALDI-TOF MS, was developed 2 decades ago to facilitate the analysis of solid compounds next to the customary volatile compounds (29).”
BackgroundMultilocus Sequence Typing of Streptococcus pneumoniae by Use of Mass Spectrometry
Dunne, E. M., Ong, E. K., Moser, R. J., Siba, P. M., Phuanukoonnon, S., Greenhill, A. R., Robins-Browne, R. M., Mulholland, K., & Satzke, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05113-11 · Cited by 25 · cited 1×
“For pneumococci, essentially the same phenomenon was observed: again a 99% overlap between MLST and MS-derived strain clusters was documented (9).”
Weigoldt, M., Meens, J., Doll, K., Fritsch, I., Möbius, P., Goethe, R., & Gerlach, G.-F. (2010) · Microbiology · doi:10.1099/mic.0.044859-0 · Cited by 20 · cited 1×
“mycobacteria (10) and their subspecies (30).”
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience
Mischak, H., Vlahou, A., & Ioannidis, J. P. A. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.025 · Cited by 213
Next-Generation Antimicrobial Susceptibility Testing
van Belkum, A., & Dunne, W. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-13 · Cited by 185
“Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS), a powerful tool for the rapid identification of organisms with medical importance, may also prove to be of value as an AST method (5).”
MethodRapid Clinical Bacteriology and Its Future Impact
van BelkuméG, A., Durand, R., Peyret, M., Chatellier, S., Zambardi, G., Schrenzel, J., Shortridge, D., Engelhardt, A., & Dunne, W. M. (2012) · Annals of Laboratory Medicine · doi:10.3343/alm.2013.33.1.14 · Cited by 149
“matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) [8]) and this will allow for further automation of laboratory procedures.”
MethodSelf-citationApplications of MALDI-TOF MS in environmental microbiology
Santos, I. C., Hildenbrand, Z. L., & Schug, K. A. (2016) · The Analyst · doi:10.1039/c6an00131a · Cited by 133
Metadata
- Authors
- van Belkum, A., Welker, M., Erhard, M., & Chatellier, S.
- Affiliations
- Erasmus MC (NL)
- bioMérieux (France) (FR)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2012-05
- Volume
- 50
- Issue
- 5
- Pages
- 1513-1517
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3347093
- OpenAlex
- W2055212262
- Cited by
- 100
- References
- 34
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 8 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 17 · 2012: 8
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- bioMérieux
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- mass spectrometry, clinical microbiology laboratory, bacterial species identification, bacterial identification, microbiological diagnosis, future applications
- MeSH terms
- Communicable Diseases, Humans, Microbiological Techniques, Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.